Home/Filings/4/0001437749-20-018610
4//SEC Filing

Xu Wang 4

Accession 0001437749-20-018610

CIK 0001389545other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 4:49 PM ET

Size

5.0 KB

Accession

0001437749-20-018610

Insider Transaction Report

Form 4
Period: 2020-08-20
Xu Wang
NEO - Sr Mgr and Controller
Transactions
  • Award

    Stock Option (right to buy)

    2020-08-20+75,00075,000 total
    Exercise: $0.99From: 2021-08-20Exp: 2030-08-20Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001807054

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:49 PM ET
Size
5.0 KB